抗体
试剂盒
多肽
探针
蛋白
组织芯片
产品中心
Product Center
Research Grade Satralizumab
All
TD-HY583046_1.jpg
TD-HY583046_2.jpg
TD-HY583046_3.jpg
- Catalog： TD-HY583046
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： Sapelizumab,SA-237,SA237,satralizumab-mwg,CAS:1535963-91-7
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Satralizumab
| Catalog No. | TD-HY583046 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Humanized |
| Isotype | IgG2-kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | sIL6R, Interleukin-6 receptor subunit alpha, CD126, IL-6R 1, IL-6R subunit alpha, Membrane glycoprotein 80, gp80, IL6R, IL-6RA, IL-6 receptor subunit alpha, IL-6R-alpha |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | P08887 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | Sapelizumab,SA-237,SA237,satralizumab-mwg,CAS:1535963-91-7 |
| Background | Satralizumab, a humanized monoclonal antibody, is a potent Interleukine-6 (IL-6) inhibitor. Satralizumab prevents dTAA formation and progression in rattus norvegicus. Satralizumab can be used for neuromyelitis optica spectrum disorder (NMOSD) and descending thoracic aorta aneurysm (dTAA) research. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
SEC-HPLC detection for Research Grade Satralizumab. |
|
|
Detects Human CD126/IL6R/IL-6RA in indirect ELISAs. |
|
|
SDS-PAGE for Research Grade Satralizumab. |